Gaxosai INC 8-K filings

Gaxos.ai Inc. shareholders approved an amendment to the 2022 Omnibus Equity Incentive Plan, increasing reserved shares, ratified auditor appointment, and elected directors at the 2026 Annual Meeting.

Gaxos.ai Inc. has sold its gaming assets and Gaxos Gaming Labs to Game Foundry AI for approximately $1.76 million in stock to streamline operations.

Gaxos.ai Inc. increased the maximum aggregate offering price under its At The Market offering agreement by an additional $1,065,001, following approximately $5.6 million in prior sales.

Gaxos.ai Inc. has increased its At The Market offering capacity by an additional $2.6 million, bringing the total potential raise to $5.6 million.

Gaxos.ai Inc. has entered into an At The Market Offering Agreement to sell up to $3 million of common stock, enhancing its capital raising flexibility.

Gaxos.ai Inc. announced the successful election of all director nominees, ratification of its independent auditor, and approval of an amendment to its equity incentive plan at its 2025 annual meeting.

Gaxos.ai Inc. announces its reincorporation from Delaware to Nevada, effective March 3, 2025, following stockholder approval.

Alex Kisin resigns from Gaxos.ai's Board and committees, with Roman Feldman appointed as his replacement, effective immediately on March 3, 2025.

Gaxos.ai Inc. has entered into agreements for a $4 million registered direct offering of common stock and warrants.

Gaxos.ai Inc. has announced a $5 million registered direct offering of common stock and warrants, priced at-the-market under Nasdaq rules.

Gaxos.ai Inc. has entered into an agreement for the exercise of existing warrants, generating $3.24 million in gross proceeds and issuing new warrants.

Gaxos.ai filed an amendment to its previous 8-K report to correct a typographical error in the purchase price of shares and warrants in a recent $3.5 million private placement.

Gaxos.ai Inc. has successfully completed a $3.5 million private placement to support its artificial intelligence initiatives.

Gaxos.ai has acquired rights to AI-enabled technology from Ultiself to accelerate the development of its Gaxos Health product offering.

Gaxos.ai Inc. has completed a 1-for-12 reverse stock split, effective March 7, 2024, with trading on a split-adjusted basis commencing March 8, 2024.

Gaxos.ai Inc. shareholders approved a reverse stock split, ratified the appointment of an independent auditor, and authorized adjournment of the special meeting if needed.